{"nct_id":"NCT03499873","title":"Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension","status":"COMPLETED","status_verified_date":"2021-01","start_date":"2018-03-28","start_date_type":"ACTUAL","primary_completion_date":"2018-10-31","primary_completion_date_type":"ACTUAL","completion_date":"2018-12-18","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["TEVA"]}